Revisiting Prostate Cancer Recurrence with PSMA PET: Atlas of Typical and Atypical Patterns of Spread.
Radiographics
; 39(1): 186-212, 2019.
Article
em En
| MEDLINE
| ID: mdl-30620699
ABSTRACT
The introduction of prostate-specific membrane antigen (PSMA) in clinical practice has revolutionized evaluation of biochemical recurrence of prostate cancer after curative-intent treatment. The high expression of this glycoprotein in prostate cancer cells makes PSMA imaging superior to the current conventional staging methods, namely bone scanning and CT. The high capability of PSMA imaging for identifying very small previously undetected lesions has been widely demonstrated in the literature, leading to a rethinking of patient management by oncologists, urologists, and radiation oncologists. The typical and predictable patterns of spread in prostate cancer are still more prevalent, such as spread to pelvic lymph nodes and bone metastasis, but different patterns of disease spread are becoming more commonly recognized with higher reliability because PSMA imaging allows detection of more typical and atypical lesions than conventional imaging. Furthermore, it is important for the reading physician to recognize and understand the typical disease spread and the most prevalent atypical prostate cancer relapses, not only to heighten the relevancy of reports but also to improve imaging consultancy in multispecialty oncologic practice. ©RSNA, 2019.
Texto completo:
1
Bases de dados:
MEDLINE
Assunto principal:
Próstata
/
Neoplasias da Próstata
/
Glutamato Carboxipeptidase II
/
Tomografia por Emissão de Pósitrons
/
Recidiva Local de Neoplasia
/
Antígenos de Superfície
Limite:
Humans
/
Male
Idioma:
En
Revista:
Radiographics
Ano de publicação:
2019
Tipo de documento:
Article